| JYSB2500021 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2025-02-05 | | Janssen Biologics BV | | | view |
| CYSB2400172 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2024-07-05 | | Hisun Biopharmaceutical Co Ltd | | | view |
| JYSB2400112 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2024-05-24 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2400028 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2024-01-31 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| JYSB2300200 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2023-11-29 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2300117 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2023-06-15 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| CYSB2300025 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Supplementary Application | 2023-02-01 | | Yuxi Genor Biotechnology Co Ltd | | | view |
| JYSB2200199 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-10-14 | | Janssen Biologics BV;Cilag AG | | | view |
| CYSB2200234 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-09-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
| CYSB2200185 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(原2) | Supplementary Application | 2022-08-01 | | Taizhou Maibotaike Pharmaceutical Co Ltd | | | view |
| JYSB2200085 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-05-20 | | Janssen Biologics BV;Cilag AG | | | view |
| JYSB2200076 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2022-04-24 | | Janssen Biologics BV;Cilag AG | | | view |
| JXSS2100022 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | Import Drug Application | 2021-04-02 | CELLTRION, Inc. | Celltrion Inc | In Review | 2021-04-02 | view |
| JYSZ2000024 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | License Renew | 2020-12-28 | 西安杨森制药有限公司 | Xian Janssen Pharmaceutical Ltd;Janssen Biologics BV;Cilag AG | Certificate Issued | 2021-07-28 | view |
| JYSB2000613 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-12-10 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2021-02-02 | view |
| CXSS2000054 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(3.3) | New Drug Application | 2020-11-04 | 玉溪嘉和生物技术有限公司 | Yuxi Genor Biotechnology Co Ltd | In Review | 2020-11-03 | view |
| JYSB2000342 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-07-08 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Certificate Issued | 2020-09-17 | view |
| JYSB2000350 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-06-30 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | Filed | 2020-07-01 | view |
| JYSB2000192 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products | Supplementary Application | 2020-05-23 | Janssen Biologics B.V. | Janssen Biologics BV;Cilag AG | In Review | 2020-05-22 | view |
| CXSS2000020 | 注射用英夫利西单抗 | infliximab | Lyophilized | Biological Products(2) | New Drug Application | 2020-05-15 | 海正生物制药有限公司 | Hisun Biopharmaceutical Co Ltd | Certificate Issued | 2021-09-28 | view |
